7 studies found for:    "Stargardt macular degeneration" [DISEASE] OR NCT00254605 [ID-NUMBER] OR NCT01278277 [ID-NUMBER] OR NCT00060749 [ID-NUMBER] OR NCT00346853 [ID-NUMBER] OR NCT00420602 [ID-NUMBER]
Show Display Options
Rank Status Study
1 Unknown  DHA Supplementation in Patients With STGD3
Condition: Dominantly Inherited Stargardt's Disease (STGD3)
Intervention: Dietary Supplement: Over the counter DHA/EPA dietary supplementation
2 Recruiting Retinal Imaging in Patients With Inherited Retinal Degenerations
Condition: Retinitis Pigmentosa
Intervention:
3 Completed Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-Like Macular Dystrophy
Condition: Macular Degeneration
Intervention: Drug: Docosahexaenoic Acid (DHA) Dietary Supplement
4 Completed Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
Condition: Macular Dystrophy, Corneal
Interventions: Drug: 4-Methylpyrazole;   Other: saline
5 Active, not recruiting Saffron Supplementation in Stargardt's Disease
Conditions: Retinal Degeneration;   Genetic Disease;   Single-Gene Defects;   Macular Dystrophy
Interventions: Dietary Supplement: Saffron supplementation;   Other: placebo
6 Recruiting Phase I/IIa Study of StarGen in Patients With Stargardt Macular Degeneration
Condition: Stargardt Disease
Intervention: Genetic: StarGen
7 Enrolling by invitation A Study to Determine the Long Term Safety, Tolerability and Biological Activity of StarGen™ in Patients With Stargardt's Macular Degeneration
Condition: Stargardt Disease
Intervention: Drug: StarGen

Indicates status has not been verified in more than two years